RayCare 2024A Interoperable With Varian TrueBeam
RayCare 2024A Interoperable With Varian TrueBeam
STOCKHOLM, May 16, 2024 /PRNewswire/ -- RaySearch Laboratories AB (publ) is proud to announce that the oncology information system RayCare* 2024A has been certified to be interoperable with Varian TrueBeam linear accelerators, version 3.0. This is the result of joint testing activities between RaySearch and Varian Medical Systems during 2024.
斯德哥尔摩，2024 年 5 月 16 日 /PRNewswire/-- RaySearch Laboratories AB（publ）自豪地宣布，肿瘤学信息系统 RayCare* 2024A 已通过认证，可与瓦里安 TrueBeam 互操作 线性加速器，版本 3.0。这是RaySearch和瓦里安医疗系统在2024年联合测试活动的结果。
In May 2023, RayCare 5B was certified to be interoperable with TrueBeam 3.0. This was 17 months after the release of RayCare 5B. The interoperability certificate for 2024A that was issued now comes already before the release of RayCare 2024A which is scheduled to be finalized in a few weeks from now.
2023 年 5 月，RayCare 5B 获得认证，可与 TrueBeam 3.0 互操作。这是在 RayCare 5B 发布后 17 个月。现在颁发的2024A互操作性证书已经在RayCare 2024A发布之前发布了，RayCare 2024A计划在几周后最终确定。
TrueBeam is Varian's most prevalent treatment delivery platform and has been installed in thousands of radiation therapy clinics in the world since its launch in 2010. It supports all treatment techniques and capabilities that are provided by so called c-arm linacs, including IMRT, VMAT and electrons with flexible beam energy selection and non-coplanar beam arrangements. The interoperability certificate applies to linacs in the TrueBeam family equipped with kV imaging: TrueBeam, TrueBeam STx, Edge and VitalBeam.
TrueBeam 是瓦里安最常用的治疗交付平台，自 2010 年推出以来，已安装在全球数千家放射治疗诊所中。它支持所谓的 C 型臂直线加速器提供的所有治疗技术和能力，包括 IMRT、VMAT 和具有灵活光束能量选择和非共面光束排列的电子。互操作性证书适用于配备 kV 成像的 TrueBeam 系列直线加速器：TrueBeam、TrueBeam STX、Edge 和 VitalBeam。
Agam Sharda, VP of Product & Portfolio Management at Varian, says: "By achieving clinical interoperability between TrueBeam and RayCare, Varian again shows our commitment to developing, deploying, and maintaining critical interfaces for our fleet to operate seamlessly. RaySearch as an alliance in our ecosystem program is another example of our resolve to meet the diverse needs of customers across the world."
瓦里安产品与产品组合管理副总裁阿加姆·沙尔达表示：“通过实现TrueBeam和RayCare之间的临床互操作性，瓦里安再次表明了我们致力于开发、部署和维护关键接口，使我们的机队能够无缝运行。作为我们生态系统计划中的一个联盟，RaySearch是我们决心满足全球客户多样化需求的又一个例子。”
Johan Löf, founder and CEO, RaySearch, says: "Interoperability with treatment delivery systems is a key feature of RayCare and it is gratifying to see that the interoperability of the latest version of RayCare with TrueBeam has been achieved in time for the release and I look forward to clinical implementation of the connection later in 2024."
RaySearch创始人兼首席执行官约翰·洛夫表示：“与治疗交付系统的互操作性是RayCare的关键特性，令人欣慰的是，最新版本的RayCare与TrueBeam的互操作性已在发布前及时实现，我期待在2024年晚些时候实现这种连接的临床实施。”
For more information, please contact:
Johan Löf, founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8 510 530 00
[email protected]
欲了解更多信息，请联系：
约翰·洛夫，RaySearch Laboratories AB（publ）创始人兼首席执行官
电话：+46 (0) 8 510 530 00
[电子邮件保护]
* Subject to regulatory clearance in some markets.
* 须经某些市场的监管许可。
This information was brought to you by Cision
这些信息是由 Cision 带给你的
The following files are available for download:
以下文件可供下载：
|
RaySearch Press Release May 16, 2024 |
|
RaySearch 新闻稿 2024 年 5 月 16 日 |
SOURCE RaySearch Laboratories
来源 RaySearch 实验室
